Cholangiocarcinoma and its management

Gut

Volumn 56, Issue 12, 2007, Pages 1755-1756

  Khan, Shahid A ^a   Miras, A ^a   Pelling, M ^a   Taylor Robinson, S D ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BILE DUCT CARCINOMA; BILIARY TRACT DRAINAGE; CLINICAL FEATURE; HUMAN; LAPAROSCOPY; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PRIORITY JOURNAL; SHORT SURVEY; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; HUMANS;

EID: 36749003691     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2007.138859     Document Type: Short Survey

References (48)

1. Taylor-Robinson SD, Toledano MB, Arora S, et al. Increase in mortality rates for intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut 2001;48:816-20.
2. Khan SA, Taylor-Robinson SD, Toledano MB, et al. Changing international trends in mortality rates for liver, biliary and pancreatic tumours 1979-1997. J Hepatol 2002;37:806-13.
3. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004;24(2):115-25.
4. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001;33:1353-7.
5. O'Grady JG. Treatment options for other malignancies. Liver Transplantation 2000;6:S23-9.
6. Khan SA, Davidson BR, Goldin R, et al. UK guidelines for the diagnosis and treatment of cholangiocarcinoma. Gut, 2002;51(Suppl 6), 1-9.
7. De Groen PC, Gores GJ, LaRusso NF, et al. Biliary tract cancers. NEJM 1999;341:1368-79.
8. Bismuth H, Castaing D. Hepatobiliary malignancy. London: Edward Arnold, 1994:416-24.
9. Gores GJ. Early detection and treatment of cholangiocarcinoma. Liver Transplantation 2000;6:S30-4.
10. Ramage JK, Donaghy A, Farrant JM, et al. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 1995;108:865-9.
11. Patel AH, Harnois DM, Klee GG, et al. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol 2000;95:204-7.
12. Hultcrantz R, Olsson R, Danielsson A, et al. A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. J Hepatol 1999;30:669-73.
13. Kuszyk BS, Soyer P, Bluemke DA, et al. Intrahepatic cholangiocarcinoma: the role of imaging in detection and staging. Crit Rev Dion Imaging 1997;38:59-88.
14. Fulcher AS, Turner MA. HASTE MR cholangiography in the evaluation of hilar cholangiocarcinoma. AJR Am J Roentgenol 1997;169:1501-5.
15. Cieszanowski A, Chomicka D, Andrzejewska M, et al. Imaging techniques in patients with biliary obstruction. Med Sci Monit 2000;6:1197-202.
16. Figueras J, Llado L, Valls C, et al. Changing strategies in diagnosis and management of hilar cholangiocarcinoma. Liver Transpl 2000;6:786-94.
17. Yeh TS, Jan YY, Tseng JH, et al. Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings. Am J Gastroenterol 2000;95:432-40.
18. Zidi SH, Prat F, Le Guen O, et al. Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures. Gut 2000;46:103-6.
19. Magnuson TH, Bender JS, Duncan MD, et al. Utility of magnetic resonance cholangiography in the evaluation of biliary obstruction. J Am Coll Surg 1999;189:63-72.
20. Chan FL, Chan JK, Leong LL. Modern imaging in the evaluation of hepatolithiasis. Hepatogastroenterology 1997;44:358-69.
21. Wiersema MJ, Vilmann P, Giovannini M, et al. Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology 1997;112:1087-95.
22. In:, Sobin LH, Wittekind C, eds. TNM Classification of Malignant Tumours: International Union Against Cancer. 5th ed. New York, NY: Wiley, 1997.
23. Henson DE, Albores-Saavedra J, Corle D. Carcinoma of the extrahepatic bile ducts. Histologic types, stage of disease, grade, and survival rates. Cancer 1992;70:1498-501.
24. Hillen HF. Unknown primary tumours. Postgrad Med J 2000;76:690-3.
25. Stevens KJ, Smith SL, Denley H, et al. Is mammography of value in women with disseminated cancer of unknown origin? Clin Oncol 1999;11:90-2.
26. Stain SC, Baer HU, Dennison AR, et al. Current management of hilar cholangiocarcinoma. Surg Gynecol Obstet 1992;175:579-88.
27. Nimura Y, Kamiya J, Nagino M, et al. Aggressive surgical treatment of hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg 1998;5:52-61.
28. Madariaga JR, Iwatsuki S, Todo S, et al. Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg 1998;227(1):70-9.
29. Iwatsuki S, Todo S, Marsh JW, et al. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 1998;187:358-64.
30. Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 2000;69:1633-7.
31. De Vreede I, Steers JL, Burch PA, et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 2000;6:309-16.
32. Heimbach JK, Gores GJ, Haddock MG, et al. Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis 2004;24:201-7.
33. Nordback IH, Pitt HA, Coleman J, et al. Unresectable hilar cholangiocarcinoma: percutaneous versus operative palliation. Surgery 1994;115:597-603.
34. Lammer J, Hausegger KA, Fluckiger F, et al. Common bile duct obstruction due to malignancy: treatment with plastic versus metal stents. Radiology 1996;201:167-72.
35. Hochwald SN, Burke EC, Jarnagin WR, et al. Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg 1999;134:261-6.
36. Nakeeb A, Pitt HA. The role of preoperative biliary decompression in obstructive jaundice. Hepatogastroenterol 1995;42:332-7.
37. Eckhard R, Abou-Rebyeh H, Adler A, et al. Magnetic resonance cholangiopancreatography guided unilateral endoscopic stent placement for Klatskin tumors. Gastrointest Endosc 2001;53:40-6.
38. Chang W-H, Kortan P, Haber GB. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc 1998;47:354-62.
39. De Palma GD, Galloro G, Sicialiano S, et al. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest Endosc 2001;53:547-53.
40. Hejna M, Pruckmayer M, Raderer M. The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. Eur J Cancer 1998;34:977-86.
41. Anderson CD, Pinson CW, Berlin J, et al. Diagnosis and treatment of cholangiocarcinoma. Oncologist 2004;9:43-57.
42. Tsavaris N, Kosmas C, Gouveris P, et al. Weekly gemcitabine for the treatment of biliary tract and gallbladder cancer. Invest New Drugs 2004;22:193-8.
43. Burris HA 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first line therapy for patients with advanced pancreatic cancer. J Clin Oncol 1997;15:2403-13.
44. Glimelius B, Hoffman K, Sjoden PO, et al. Chemotherapy improves survival and quality of life in advanced biliary and pancreatic cancer. Ann Oncol 1996;7:593-600.
45. Ducreux M, Rougier P, Fandi A, et al. Effective treatment of advanced bilary tract carcinoma using 5-FU continuous infusion with cisplatin. Ann Oncol 1998;9:653-56.
46. Bowling TE, Galbraith SM, Hatfield AR, et al. A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma. Gut 1996;39:852-5.
47. Foo ML, Gunderson LL, Bender CE, et al. External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys 1997;39:929-35.
48. Pitt HA, Nakeeb A, Abrams RA, et al. Peri-hilar cholangiocarcinoma: Post-operative radiation therapy does not improve survival. Ann Surg 1995;221:788-98.